Matricelf
Matricelf
Agent26Agent Readiness: 26/100. Bottom 25%. Measured by StartupHub.ai. Median 41.Develops autologous engineered tissue from omentum biopsies for medical conditions.
About
Matricelf is developing a revolutionary regenerative medicine platform to treat spinal cord injury (SCI) and other medical conditions like stroke and traumatic brain injury. Their proprietary technology engineers functional neural implants using a patient's own induced pluripotent stem cells (iPSCs) differentiated within a personalized extracellular matrix (ECM) hydrogel. This approach aims to restore lost function by bridging damaged spinal tissue with reduced rejection risk.
Key facts
At-a-glance profile data
- Website
- matricelf.com
- Headquarters
- Tel Aviv, Israel
- Founded
- 2019
- Employees
- 20
- Total funding
- -
- Business model
- B2B
Tech stack
Detected on matricelf.com, last scanned 6 Sept 2026. Run your own scan
- Frontend
- jQuery, Tailwind CSS
- Analytics
- Google Analytics 4
- SEO
- Yoast SEO, All in One SEO
- CMS / Builders
- WordPress
- CDN
- Cloudflare
- Email provider
- Microsoft 365
- Video / media
- Vimeo
Add first review
Frequently asked
How many employees does Matricelf have?
Matricelf has approximately 20 people on record.